Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor e...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd118 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:98e457b86fcb4a24a353e7b87bdcd118 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:98e457b86fcb4a24a353e7b87bdcd1182021-11-25T17:03:26ZDiagnostic Accuracy of Liquid Biopsy in Endometrial Cancer10.3390/cancers132257312072-6694https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd1182021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5731https://doaj.org/toc/2072-6694Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor educated platelets (TEPs) and circulating tumor DNA (ctDNA) for preoperative EC diagnosis, including histology determination. Methods: TEPs from 295 subjects (53 EC patients, 38 patients with benign gynecologic conditions, and 204 healthy women) were RNA-sequenced. DNA sequencing data were obtained for 519 primary tumor tissues and 16 plasma samples. Artificial intelligence was applied to sample classification. Results: Platelet-dedicated classifier yielded AUC of 97.5% in the test set when discriminating between healthy subjects and cancer patients. However, the discrimination between endometrial cancer and benign gynecologic conditions was more challenging, with AUC of 84.1%. ctDNA-dedicated classifier discriminated primary tumor tissue samples with AUC of 96% and ctDNA blood samples with AUC of 69.8%. Conclusions: Liquid biopsies show potential in EC diagnosis. Both TEPs and ctDNA profiles coupled with artificial intelligence constitute a source of useful information. Further work involving more cases is warranted.Marta ŁukasiewiczKrzysztof PastuszakSylwia Łapińska-SzumczykRobert RóżańskiSjors G. J. G. In ‘t VeldMichał BieńkowskiTomasz StokowyMagdalena RatajskaMyron G. BestThomas WürdingerAnna J. ŻaczekAnna SupernatJacek JassemMDPI AGarticleendometrial cancertumor educated plateletscirculating tumor DNAmolecular markersliquid biopsyartificial intelligenceNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5731, p 5731 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
endometrial cancer tumor educated platelets circulating tumor DNA molecular markers liquid biopsy artificial intelligence Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
endometrial cancer tumor educated platelets circulating tumor DNA molecular markers liquid biopsy artificial intelligence Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Marta Łukasiewicz Krzysztof Pastuszak Sylwia Łapińska-Szumczyk Robert Różański Sjors G. J. G. In ‘t Veld Michał Bieńkowski Tomasz Stokowy Magdalena Ratajska Myron G. Best Thomas Würdinger Anna J. Żaczek Anna Supernat Jacek Jassem Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
description |
Background: Liquid biopsy is a minimally invasive collection of a patient body fluid sample. In oncology, they offer several advantages compared to traditional tissue biopsies. However, the potential of this method in endometrial cancer (EC) remains poorly explored. We studied the utility of tumor educated platelets (TEPs) and circulating tumor DNA (ctDNA) for preoperative EC diagnosis, including histology determination. Methods: TEPs from 295 subjects (53 EC patients, 38 patients with benign gynecologic conditions, and 204 healthy women) were RNA-sequenced. DNA sequencing data were obtained for 519 primary tumor tissues and 16 plasma samples. Artificial intelligence was applied to sample classification. Results: Platelet-dedicated classifier yielded AUC of 97.5% in the test set when discriminating between healthy subjects and cancer patients. However, the discrimination between endometrial cancer and benign gynecologic conditions was more challenging, with AUC of 84.1%. ctDNA-dedicated classifier discriminated primary tumor tissue samples with AUC of 96% and ctDNA blood samples with AUC of 69.8%. Conclusions: Liquid biopsies show potential in EC diagnosis. Both TEPs and ctDNA profiles coupled with artificial intelligence constitute a source of useful information. Further work involving more cases is warranted. |
format |
article |
author |
Marta Łukasiewicz Krzysztof Pastuszak Sylwia Łapińska-Szumczyk Robert Różański Sjors G. J. G. In ‘t Veld Michał Bieńkowski Tomasz Stokowy Magdalena Ratajska Myron G. Best Thomas Würdinger Anna J. Żaczek Anna Supernat Jacek Jassem |
author_facet |
Marta Łukasiewicz Krzysztof Pastuszak Sylwia Łapińska-Szumczyk Robert Różański Sjors G. J. G. In ‘t Veld Michał Bieńkowski Tomasz Stokowy Magdalena Ratajska Myron G. Best Thomas Würdinger Anna J. Żaczek Anna Supernat Jacek Jassem |
author_sort |
Marta Łukasiewicz |
title |
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
title_short |
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
title_full |
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
title_fullStr |
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
title_full_unstemmed |
Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer |
title_sort |
diagnostic accuracy of liquid biopsy in endometrial cancer |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/98e457b86fcb4a24a353e7b87bdcd118 |
work_keys_str_mv |
AT martałukasiewicz diagnosticaccuracyofliquidbiopsyinendometrialcancer AT krzysztofpastuszak diagnosticaccuracyofliquidbiopsyinendometrialcancer AT sylwiałapinskaszumczyk diagnosticaccuracyofliquidbiopsyinendometrialcancer AT robertrozanski diagnosticaccuracyofliquidbiopsyinendometrialcancer AT sjorsgjgintveld diagnosticaccuracyofliquidbiopsyinendometrialcancer AT michałbienkowski diagnosticaccuracyofliquidbiopsyinendometrialcancer AT tomaszstokowy diagnosticaccuracyofliquidbiopsyinendometrialcancer AT magdalenaratajska diagnosticaccuracyofliquidbiopsyinendometrialcancer AT myrongbest diagnosticaccuracyofliquidbiopsyinendometrialcancer AT thomaswurdinger diagnosticaccuracyofliquidbiopsyinendometrialcancer AT annajzaczek diagnosticaccuracyofliquidbiopsyinendometrialcancer AT annasupernat diagnosticaccuracyofliquidbiopsyinendometrialcancer AT jacekjassem diagnosticaccuracyofliquidbiopsyinendometrialcancer |
_version_ |
1718412791418716160 |